Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mounia Slaoui"'
Autor:
Ali Azghar, Mohammed Bensalah, Abdelilah Berhili, Mounia Slaoui, Boutaina Mouhoub, Imane El Mezgueldi, Oumaima Nassiri, Jalila El Malki, Adil Maleb, Rachid Seddik
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations and the evolution of patients with COVID-19 are variable. In addition to respiratory involvement,
Externí odkaz:
https://doaj.org/article/801abe8d4eda48eeb264db20939457e9
Autor:
Boutaina Mouhoub, Mohammed Bensalah, Abdelilah Berhili, Ali Azghar, Jalila El Malki, Imane El Mezgueldi, Oumaima Nassiri, Mounia Slaoui, Achraf Miri, Chaymae Rochdi, Noufissa Benajiba, Rachid Seddik
Publikováno v:
IDCases, Vol 26, Iss , Pp e01247- (2021)
Background: The combination of visceral leishmaniasis (VL) and macrophage activation syndrome (MAS) makes the diagnosis difficult due to their similar clinical presentation, with a poor prognosis especially since the treatment is still poorly codifie
Externí odkaz:
https://doaj.org/article/c2feb82494454907b2cad7cb3c5f6fe6
Autor:
Julien, Rossignol, Christophe, Marzac, Azeddine, Dellal, Nabil, Belfeki, Vincent, Jachiet, Mounia, Slaoui, Davy, Benarroche, Sophie, Georgin-Lavialle, Eric, Solary, Olivier, Hermine, Olivier, Fain, Arsène, Mekinian
Publikováno v:
Clinical rheumatology. 41(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc714b8fecf566146407c41eeffd63e4
https://pubmed.ncbi.nlm.nih.gov/35094194
https://pubmed.ncbi.nlm.nih.gov/35094194
Autor:
Oumaima Nassiri, Boutaina Mouhoub, Noufissa Benajiba, Abdelilah Berhili, Rachid Seddik, Imane El Mezgueldi, Chaymae Rochdi, Mohammed Bensalah, Jalila El Malki, Achraf Miri, Mounia Slaoui, Ali Azghar
Publikováno v:
IDCases
IDCases, Vol 26, Iss, Pp e01247-(2021)
IDCases, Vol 26, Iss, Pp e01247-(2021)
Background The combination of visceral leishmaniasis (VL) and macrophage activation syndrome (MAS) makes the diagnosis difficult due to their similar clinical presentation, with a poor prognosis especially since the treatment is still poorly codified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3d9139b5a020c4d1cb6c8328774035
http://europepmc.org/articles/PMC8371194
http://europepmc.org/articles/PMC8371194
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 15(8)
Five patients with severe haemophilia A and high responding inhibitors underwent laparoscopic or open surgery on the digestive tract (appendicectomy, cholecystectomy, partial colectomy, or haemorrhoidectomy) with recombinant activated factor VII (rFV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f83af1ddb6c1860faa754800cab4e6
https://pubmed.ncbi.nlm.nih.gov/15613924
https://pubmed.ncbi.nlm.nih.gov/15613924
Publikováno v:
Blood. 106:4068-4068
The prevention of bleeding by prophylaxis regimen particularly for joint rehabilitation, could be considered a more effective treatment for hemophilia patients. In hemophiliacs with factor VIII inhibitor (F VIII inh) prophylaxis is not generally prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d702676bb1dc03aef2204fc506428c55
https://doi.org/10.1182/blood.v106.11.4068.4068
https://doi.org/10.1182/blood.v106.11.4068.4068
Publikováno v:
Blood. 104:3982-3982
Caen Haemophilia centre monitored 343 haemophilia A patients, 62 of them with a severe defect. We report here the preliminary results of genotypes and factor VIII (FVIII) inhibitors response for the first 59 and particularly for 15 patients with FVII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bed8dd3d90f8445d6ee0b668e6363da
https://doi.org/10.1182/blood.v104.11.3982.3982
https://doi.org/10.1182/blood.v104.11.3982.3982